Recent approaches for reducing hemolytic activity of chemotherapeutic agents

Journal of Controlled Release

Volumn 211, Issue , 2015, Pages 10-21

  Jeswani, Gunjan ^b   Alexander, Amit ^a   Saraf, Shailendra ^c   Saraf, Swarnlata ^c   Qureshi, Azra ^a   Ajazuddin, ^a  

^a RUNGTA COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^b Department of CSE (FET)   (India)

^c PT RAVISHANKAR SHUKLA UNIVERSITY   (India)

Author keywords

Chemotherapeutic agent; Colloidal carriers; Hemolysis; Polymer drug conjugation

Indexed keywords

BLOOD; CELL MEMBRANES; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; MOLECULES; POLYMERS;

CHEMOTHERAPEUTIC AGENTS; COLLOIDAL CARRIERS; ERYTHROCYTE MEMBRANE; FOOD AND DRUG ADMINISTRATION; HEMOLYSIS; MOLECULAR CHEMISTRY; MOLECULAR MODIFICATION; POLYMER-DRUG CONJUGATION;

TARGETED DRUG DELIVERY;

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CHITOSAN; DRUG CARRIER; GEMCITABINE; OLEATE SODIUM; PACLITAXEL; PNEUMOLYSIN; POLYMER; ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICAL MODIFICATION; CHEMOTHERAPY; CONJUGATION; CYTOLYSIS; DOSE RESPONSE; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FOOD AND DRUG ADMINISTRATION; GUAVA; HEMOLYSIS; HUMAN; HYDROGEL; MAYTENUS; MICELLE; MICROENCAPSULATION; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; SILYBUM MARIANUM; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMANS;

EID: 84930943924     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.06.001     Document Type: Review

References (57)

1. M. Maier-Redelsperger, P. Lévy, F. Lionnet, K. Stankovic, J.-P. Haymann, G. Lefèvre, V. Avellino, J.-P. Perol, R. Girot, and J. Elion Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia Blood Cells Mol. Dis. 45 2010 289 292
2. M. Sirdah, N.S. Reading, S.L. Perkins, M. Shubair, L. Aboud, and J.T. Prchal Hemolysis and Mediterranean G6PD mutation (c.563 C > T) and c.1311 C > T polymorphism among Palestinians at Gaza Strip Blood Cells Mol. Dis. 48 2012 203 208
3. A. Pierce, and T. Nester Pathology consultation on drug-induced hemolytic anemia Am. J. Clin. Pathol. 136 2011 7 12
4. S.S. Davis Biomedical applications of nanotechnology - implications for drug targeting and gene therapy Trends Biotechnol. 15 1997 217 224
5. M.N. Ton, C. Chang, Y.A. Carpentier, R.J. Deckelbaum, In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides, Clin. Nutr. 24 492-501.
6. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
7. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science (New York, N.Y.) 263 1994 1600 1603
8. M. Sellami, A. Châari, I. Aissa, M. Bouaziz, Y. Gargouri, and N. Miled Newly synthesized dopamine ester derivatives and assessment of their antioxidant, antimicrobial and hemolytic activities Process Biochem. 48 2013 1481 1487
9. J. de A. Pachioni, J.G. Magalhaes, E.J. Lima, L. de M. Bueno, J.F. Barbosa, M.M. de Sa, and C.O. Rangel-Yagui Alkylphospholipids - a promising class of chemotherapeutic agents with a broad pharmacological spectrum J. Pharm. Pharm. Sci. 16 2013 742 759
10. M. Jumaa, and B.W. Müller Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect Eur. J. Pharm. Sci. 9 2000 285 290
11. M.M. Cruz Silva, V.M. Madeira, L.M. Almeida, and J.B. Custodio Hydroxytamoxifen interaction with human erythrocyte membrane and induction of permeabilization and subsequent hemolysis Toxicol. in Vitro 15 2001 615 622
12. C. Gauthier, J. Legault, K. Girard-Lalancette, V. Mshvildadze, and A. Pichette Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins Bioorg. Med. Chem. 17 2009 2002 2008
13. N. Larson, and H. Ghandehari Polymeric conjugates for drug delivery Chem. Mater. 24 2012 840 853
14. G. Pasut, and F.M. Veronese Polymer-drug conjugation, recent achievements and general strategies Prog. Polym. Sci. 32 2007 933 961
15. Ajazuddin, A. Alexander, B. Amarji, and P. Kanaujia Synthesis, characterization and in vitro studies of pegylated melphalan conjugates Drug Dev. Ind. Pharm. 39 2013 1053 1062
16. A. Alexander, S. Saraf, and S. Saraf A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates Drug Dev. Ind. Pharm. 2015 1 8
17. G.P. Kumar, and P. Rajeshwarrao Nonionic surfactant vesicular systems for effective drug delivery - an overview Acta Pharm. Sin. B 1 2011 208 219
18. C. Deng, Y. Jiang, R. Cheng, F. Meng, and Z. Zhong Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects Nano Today 7 2012 467 480
19. A. Falamarzian, and A. Lavasanifar Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(ε-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B Colloids Surf. B Biointerfaces 81 2010 313 320
20. A. Lavasanifar, J. Samuel, and G.S. Kwon Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate l-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B J. Control. Release 77 2001 155 160
21. G. Vandermeulen, L. Rouxhet, A. Arien, M.E. Brewster, and V. Préat Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(ε-caprolactone-co-trimethylenecarbonate) polymeric micelles Int. J. Pharm. 309 2006 234 240
22. X. Li, Z. Yang, K. Yang, Y. Zhou, X. Chen, Y. Zhang, F. Wang, Y. Liu, and L. Ren Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen Nanoscale Res. Lett. 4 2009 1502 1511
23. X. Shuai, H. Ai, N. Nasongkla, S. Kim, and J. Gao Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery J. Control. Release 98 2004 415 426
24. J. Park, M. Ye, and K. Park Biodegradable polymers for microencapsulation of drugs Molecules 10 2005 146 161
25. D.R. Serrano, L. Hernández, L. Fleire, I. González-Alvarez, A. Montoya, M.P. Ballesteros, M.A. Dea-Ayuela, G. Miró, F. Bolás-Fernández, and J.J. Torrado Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations Int. J. Pharm. 447 2013 38 46
26. H.-J. Doh, Y. Jung, P. Balakrishnan, H.-J. Cho, and D.-D. Kim A novel lipid nanoemulsion system for improved permeation of granisetron Colloids Surf. B Biointerfaces 101 2013 475 480
27. Charles Lovelyn, and A.A. Attama Current state of nanoemulsions in drug delivery J. Biomater. Nanobiotechnol. 2 2011 626 639
28. X. Jing, L. Deng, B. Gao, L. Xiao, Y. Zhang, X. Ke, J. Lian, Q. Zhao, L. Ma, J. Yao, and J. Chen A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel Nanomed. Nanotechnol. Biol. Med. 10 2013 371 380
29. M.H. Alkhatib, and N.S. Alkhayyal Cytotoxicity of gemcitabine-loaded-microemulsions in breast and colon cancer cells Trop. J. Pharm. Res. 13 2013 217 224
30. M. Jumaa, F.H. Furkert, and B.W. Müller A new lipid emulsion formulation with high antimicrobial efficacy using chitosan Eur. J. Pharm. Biopharm. 53 2002 115 123
31. A.O. Nornoo, D.W. Osborne, and D.S.L. Chow Cremophor-free intravenous microemulsions for paclitaxel: I: formulation, cytotoxicity and hemolysis Int. J. Pharm. 349 2008 108 116
32. Y. Wang, K.C. Wu, B.X. Zhao, X. Zhao, X. Wang, S. Chen, S.F. Nie, W.S. Pan, X. Zhang, and Q. Zhang A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety J. Biomed. Biotechnol. 2011 2011 854872
33. G. Jeswani, and S. Saraf Topical delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles Pharm. Drug Deliv. Res. 3 2013 1
34. M. Brewer Natural antioxidants: sources, compounds, mechanisms of action, and potential applications Compr. Rev. Food Sci. Food Saf. 10 2011 221 247
35. N. Ramadass, S. Kombiyil, N.K. Kasinathan, and N.D. Sivasithamparam Attenuation of mitochondrial oxidative stress by morin during chemical carcinogen-mediated mammary carcinogenesis Biomed. Prev. Nutr. 2 2012 9 15
36. F. Takano, T. Tanaka, J. Aoi, N. Yahagi, and S. Fushiya Protective effect of (+)-catechin against 5-fluorouracil-induced myelosuppression in mice Toxicology 201 2004 133 142
37. J.R. Shak, H.P. Ludewick, K.E. Howery, F. Sakai, H. Yi, R.M. Harvey, J.C. Paton, K.P. Klugman, and J.E. Vidal Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms mBio 4 2013 (e00655-00613)
38. A. Rabinkov, T. Miron, L. Konstantinovski, M. Wilchek, D. Mirelman, and L. Weiner The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins Biochim. Biophys. Acta Gen. Subj. 1379 1998 233 244
39. M. Arzanlou, S. Bohlooli, E. Jannati, and H. Mirzanejad-Asl Allicin from garlic neutralizes the hemolytic activity of intra- and extra-cellular pneumolysin O in vitro Toxicon 57 2011 540 545
40. Yoke Keong Yong, Jun Jie Tan, Soek Sin Teh, Siau Hui Mah, Gwendoline Cheng Lian Ee, Hoe Siong Chiong, and Z. Ahmad Clinacanthus nutans extracts are antioxidant with antiproliferative effect on cultured human cancer cell lines Evid. Based Complement. Alternat. Med. 8 2013 1 3
41. B.H. Marouf, M.H. Zalzala, I.I. Al-Khalifa, T.A. Aziz, and S.A. Hussain Free radical scavenging activity of silibinin in nitrite-induced hemoglobin oxidation and membrane fragility models Saudi Pharm. J. 19 2011 177 183
42. M. Shabbir, M. Khan, and N. Saeed Assessment of phytochemicals, antioxidant, anti-lipid peroxidation and anti-hemolytic activity of extract and various fractions of Maytenus royleanus leaves BMC Complement. Alternat. Med. 13 2013 1 13
43. C. Thephinlap, K. Pangjit, M. Suttajit, and S. Srichairatanakool Anti-oxidant properties and anti-hemolytic activity of Psidium guajava, Pandanous odorus and Rhinacanthus nasutus J. Med. Plants Res. 7 2013 2001 2009
44. M. Tamaki, K. Fujinuma, T. Harada, K. Takanashi, M. Shindo, M. Kimura, and Y. Uchida Fatty acyl-gramicidin S derivatives with both high antibiotic activity and low hemolytic activity Bioorg. Med. Chem. Lett. 22 2012 106 109
45. M. Arias, J.C. Quijano, V. Haridas, J.U. Gutterman, and V.V. Lemeshko Red blood cell permeabilization by hypotonic treatments, saponin, and anticancer avicins Biochim. Biophys. Acta Biomembr. 1798 2010 1189 1196
46. M.M. Cruz Silva, V.M. Madeira, L.M. Almeida, and J.B. Custodio Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure Biochim. Biophys. Acta 1464 2000 49 61
47. J.A. Hurteau, M.F. Brady, K.M. Darcy, W.P. McGuire, P. Edmonds, M.L. Pearl, I. Ivanov, K.S. Tewari, R.S. Mannel, K. Zanotti, and D.M. Benbrook Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study Gynecol. Oncol. 119 2010 444 450
48. A.C. de Oliveira, E.A. Hillard, P. Pigeon, D.D. Rocha, F.A.R. Rodrigues, R.C. Montenegro, L.V. Costa-Lotufo, M.O.F. Goulart, and G. Jaouen Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: cancer cell growth inhibition, ROS production and hemolytic activity Eur. J. Med. Chem. 46 2011 3778 3787
49. S.M. Kim, J.M. Kim, H. Cho, and K.H. Lee Synthesis of antibacterial pseudopeptides with less hemolytic activity from a cytotoxic peptide and their pH-dependent activity Bioorg. Med. Chem. Lett. 19 2009 5627 5631
50. M. Abdolhosseini, S.R. Nandula, J. Song, H. Hirt, and S.U. Gorr Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity Peptides 35 2012 231 238
51. B. Findlay, G.G. Zhanel, and F. Schweizer Neomycin-phenolic conjugates: polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding Bioorg. Med. Chem. Lett. 22 2012 1499 1503
52. M. Tamaki, Y. Imazeki, A. Shirane, K. Fujinuma, M. Shindo, M. Kimura, and Y. Uchida Novel gratisin derivatives with high antimicrobial activity and low hemolytic activity Bioorg. Med. Chem. Lett. 21 2011 440 443
53. M. Tamaki, M. Kokuno, I. Sasaki, Y. Suzuki, M. Iwama, K. Saegusa, Y. Kikuchi, M. Shindo, M. Kimura, and Y. Uchida Syntheses of low-hemolytic antimicrobial gratisin peptides Bioorg. Med. Chem. Lett. 19 2009 2856 2859
54. W. Li, Z. Qiu, Y. Wang, Y. Zhang, M. Li, J. Yu, L. Zhang, Z. Zhu, and B. Yu Synthesis, cytotoxicity, and hemolytic activity of 6′-O-substituted dioscin derivatives Carbohydr. Res. 342 2007 2705 2715
55. W.J. van Blitterswijk, and M. Verheij Anticancer mechanisms and clinical application of alkylphospholipids Biochim. Biophys. Acta 1831 2013 663 674
56. X. Jing, L. Deng, B. Gao, L. Xiao, Y. Zhang, X. Ke, and J. Lian A novel polyethylene glycol mediated lipid nanoemulsion as drug delivery carrier for paclitaxel Nanomed. Nanotechnol. Biol. Med. 10 2 2014 371 380
57. D.R. Serrano, L. Hernández, L. Fleire, I. González-Alvarez, A. Montoya, M.P. Ballesteros, M.A. Dea-Ayuela, G. Miró, F. Bolás-Fernández, and J.J. Torrado Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations Int. J. Pharm. 447 1-2 2013 38 46